-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the CDE official website showed that the quetiapine fumarate tablets of Shantowei Pharmaceutical were accepted for production as a generic Category 4 product
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
Quetiapine fumarate is an atypical antipsychotic drug mainly used for the treatment of schizophrenia and for the treatment of manic episodes in bipolar disorder
.
.
Sales of Quetiapine Fumarate Tablets in Chinese Urban Physical Pharmacy Terminals in Recent Years (Unit: 10,000 yuan)
Source: Competitive landscape of physical pharmacy terminals in Chinese cities
According to the data of Minet.
com, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
com, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
2021E Top 5 Antipsychotic Drug Products in China's Urban Physical Pharmacies
Source: Minet.
com China's urban physical pharmacy terminal competition pattern
com China's urban physical pharmacy terminal competition pattern
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in Chinese urban brick-and-mortar pharmacies, and is also the only positive growth product in the TOP5
.
.
At present, there are 5 manufacturers of quetiapine fumarate tablets , among which, 4 domestic enterprises including Hunan Dongting Pharmaceutical Co.
, Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
, Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
A few days ago, the CDE official website showed that the quetiapine fumarate tablets of Shantowei Pharmaceutical were accepted for production as a generic Category 4 product
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
Quetiapine fumarate is an atypical antipsychotic drug mainly used for the treatment of schizophrenia and for the treatment of manic episodes in bipolar disorder
.
.
Sales of Quetiapine Fumarate Tablets in Chinese Urban Physical Pharmacy Terminals in Recent Years (Unit: 10,000 yuan)
Source: Competitive landscape of physical pharmacy terminals in Chinese cities
According to the data of Minet.
com, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
com, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
2021E Top 5 Antipsychotic Drug Products in China's Urban Physical Pharmacies
Source: Minet.
com China's urban physical pharmacy terminal competition pattern
com China's urban physical pharmacy terminal competition pattern
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in Chinese urban brick-and-mortar pharmacies, and is also the only positive growth product in the TOP5
.
.
At present, there are 5 manufacturers of quetiapine fumarate tablets , among which, 4 domestic enterprises including Hunan Dongting Pharmaceutical Co.
, Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
, Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
A few days ago, the CDE official website showed that the quetiapine fumarate tablets of Shantowei Pharmaceutical were accepted for production as a generic Category 4 product
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
.
According to Minet.
com data, the total sales of quetiapine fumarate tablets in Chinese public medical institutions and Chinese urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in physical pharmacies in Chinese cities
.
Quetiapine fumarate is an atypical antipsychotic drug mainly used for the treatment of schizophrenia and for the treatment of manic episodes in bipolar disorder
.
.
Sales of Quetiapine Fumarate Tablets in Chinese Urban Physical Pharmacy Terminals in Recent Years (Unit: 10,000 yuan)
Source: Competitive landscape of physical pharmacy terminals in Chinese cities
According to the data of Minet.
com, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
Hospital Hospital Hospital Pharmacy Pharmacy Pharmacycom, the total sales of quetiapine fumarate tablets in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) and China's urban physical pharmacies in 2020 will exceed 1.
5 billion yuan, of which AstraZeneca has the largest market share
.
Quetiapine Fumarate Tablets is the third batch of domestic varieties, and Hunan Dongting Pharmaceutical Co.
, Ltd.
, Hefei Yingtai Pharmaceutical Co.
, Ltd.
, and Suzhou No.
1 Pharmaceutical Co.
, Ltd.
won the bid
.
In the first half of 2021, the terminal of China's public medical institutions fell by more than 40% year-on-year, while the terminal of physical pharmacy in China's urban areas is expected to increase by 3.
64% year-on-year in 2021
.
2021E Top 5 Antipsychotic Drug Products in China's Urban Physical Pharmacies
Source: Minet.
com China's urban physical pharmacy terminal competition pattern
com China's urban physical pharmacy terminal competition pattern
It is worth mentioning that Quetiapine Fumarate Tablets ranks second among terminal antipsychotic drug products in Chinese urban brick-and-mortar pharmacies, and is also the only positive growth product in the TOP5
.
.
At present, there are 5 manufacturers of quetiapine fumarate tablets , among which, 4 domestic enterprises including Hunan Dongting Pharmaceutical Co.
, Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
enterprise enterprise enterprise , Ltd.
and Guangdong Dongguang Pharmaceutical Co.
, Ltd.
have been reviewed
.
Four companies including Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical and Dr.
Ruidi (Beijing) Pharmaceutical have submitted their listing applications and are under review and approval
.
